EC extends approval of Benlysta to treat children with lupus
The EC approval is based on data from the Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 Oct 19
The EC approval is based on data from the Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy…
25 Oct 19
Allergan said that the FDA has granted the approval based on a Phase 3 study that evaluated the…
23 Oct 19
The patients treated with aducanumab have experienced enhanced measures of cognition and function including memory, orientation, and language
22 Oct 19
The transaction is expected to be completed by the end of 2019, subject to the anti-trust approval and…
16 Oct 19
Both Acino and Takeda would sign a multi-year manufacturing and supply agreement, under which Takeda would continue the…
07 Oct 19
FASENRA is currently approved as an add-on maintenance treatment for severe eosinophilic asthma in the US, EU, Japan…
04 Oct 19
PrEP is an HIV prevention method designed to reduce the risk of getting HIV in people, who do…
03 Oct 19
Insulin glargine is a long-acting basal insulin analogue, administered once daily to control the blood sugar levels in…
27 Sep 19
Mavyret marks the first eight-week treatment approved for patients with HCV genotypes 1-6 both without cirrhosis and with…
25 Sep 19
Pfizer and Flatiron Health have expanded collaboration to jointly work on integrating real-world evidence for breast cancer medicines